One of the small-cap stocks specializes in providing healthcare-focused technology-enabled solutions and services primarily to U.S.-based clients in the payer and provider segments. The stock hit a 5 percent upper circuit after JP Morgan set a 16% upside target.
What Happened:
With a market capitalization of Rs. 22,896.38 crores, the shares of Sagility India Limited’s stock surged by 5 percent, reaching an upper circuit of Rs. 48.91 per share on Thursday, up from its previous closing price of Rs. 46.59 per share.
What is the news?
JPMorgan has assigned an “overweight” rating to Sagility India Limited, with a target price of Rs 54. This target price reflects a 16% potential upside from the stock’s previous day close of Rs 46.59.
Target Rational:
JPMorgan projects a strong 50% compound annual growth rate (CAGR) in earnings for Sagility India Limited over FY24-27, citing the company’s solid positioning in the niche healthcare services segment. This growth outlook is supported by Sagility’s focus on non-discretionary spending, providing stability even amid uncertain market conditions.
JPMorgan also highlights Sagility’s ability to benefit from the growing trend of outsourcing in the U.S. healthcare sector. With its robust financial strength and high EBIT margins, Sagility is well-equipped to maintain profitability and resilience, offering a dependable revenue stream.
Growth Strategy:
Sagility India Limited’s growth strategy focuses on expanding service offerings to existing clients to increase wallet share. The company is also targeting mid-market and small clients to diversify its client base and reduce concentration risk, with a goal to reduce the contribution of top clients from 80% to 60-65% in the coming years.
Future Outlook:
Sagility India Limited’s management expects sustained growth, fueled by strong client relationships and successful penetration into the mid-market segment.
The company’s EBITDA margins are anticipated to remain steady, backed by improved operational efficiencies and strategic investments in technology, positioning the company for continued success in the future.
Also read…
Technological Investments:
Sagility India Limited is making significant technological investments to enhance operational capabilities. This includes deploying GenAI technologies across various operations, such as front-office interactions and clinical documentation, aiming to drive efficiency and improve service quality.
Service Portfolio:
Sagility India Limited provides a broad service portfolio, including claims processing, payment integrity, clinical services, and administrative support. It derives 89.2% of its revenues from payers and 10.8% from providers. The company has seen significant growth in clinical services as clients increasingly outsource due to the U.S. clinician shortage.
Clientele:
Sagility India Limited serves a strong client base, including five of the top 10 U.S. health insurers, such as UnitedHealthcare and Cigna, along with renowned healthcare providers like Johns Hopkins Hospital and Cleveland Clinic. These partnerships highlight the company’s expertise in delivering transformative solutions across the healthcare ecosystem, benefiting both insurers and providers.
IPO Details:
Sagility India Limited launched an Initial Public Offering (IPO) valued at Rs. 2,106.60 crores, which is scheduled to run from November 5 to 7, 2024. The IPO consists entirely of an offer-for-sale of 70.22 lakh shares, priced between Rs. 28 and Rs. 30 per share.
Recent quarter results and ratios:
Sagility India Limited’s revenue has increased from Rs. 1,094 crore in Q2 FY24 to Rs. 1,325 crore in Q2 FY25, which has grown by 21.12 percent. The net profit of Sagility India Limited has also grown by 235.29 percent from Rs. 35 crore in Q2 FY24 to Rs. 117 crore in Q2 FY25.
In terms of return ratios, the company’s ROCE and ROE should be 4.71 percent and 3.60 percent, respectively. The debt-to-equity ratio of the company is to be 0.19x, which shows the company is almost debt-free. Sagility India Limited’s EPS is to be Rs. 0.53.
Company Overview:
Sagility India Limited was previously known as Berkmeer India Pvt. Ltd. and is a healthcare-focused technology and services provider headquartered in Bangalore, India. The company was established in July 2021 and specializes in offering technology-enabled solutions primarily to U.S.-based clients in the healthcare sector, with a focus on the payer and provider segments.
Written By – Nikhil Naik
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
Start Your Stock Market Journey Today!
Want to learn Stock Market trading and Investing? Make sure to check out exclusive Stock Market courses by FinGrad, the learning initiative by Trade Brains. You can enroll in FREE courses and webinars available on FinGrad today and get ahead in your trading career. Join now!!
